FDA Import Refusal 799-4534182-2/11/1 — Glaxosmithkline
The FDA refused shipment 799-4534182-2/11/1 from Glaxosmithkline (United Kingdom) on Dec 16, 2019. The refused product falls under Drugs and Biologics — BUPROPION HCL (ANTI-DEPRESSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Dec 16, 2019
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 61NDB05 BUPROPION HCL (ANTI-DEPRESSANT)
- Charges
- 75